Home Compare UTHR
Peer Analysis

United Therapeutics Corporation — Peer Companies & Stock Comparisons

United Therapeutics Corporation's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare UTHR with peers
Comparison UTHR peer score
United Therapeutics Corporation vs Visa Inc.
74 Compare →
United Therapeutics Corporation vs Partners Group Holding AG
58 Compare →
United Therapeutics Corporation vs Scout24 SE
71 Compare →
United Therapeutics Corporation vs Mastercard Incorporated
70 Compare →
United Therapeutics Corporation vs MSCI Inc.
58 Compare →
United Therapeutics Corporation vs Gaztransport & Technigaz SA
77 Compare →
United Therapeutics Corporation vs TransDigm Group Incorporated
59 Compare →
United Therapeutics Corporation vs Microsoft Corporation
75 Compare →
United Therapeutics Corporation vs Moody's Corporation
63 Compare →
United Therapeutics Corporation vs Novo Nordisk A/S
58 Compare →

Full UTHR analysis in AssetNext

View the complete United Therapeutics Corporation report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.